Gyre Therapeutics, Inc. GYRE Other income, net (Note 6)
Other income, net (Note 6) at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Gyre Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Gyre Therapeutics, Inc.'s other income, net (note 6).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Gyre Therapeutics, Inc.'s other income, net (note 6)?
- Gyre Therapeutics, Inc. (GYRE) reported other income, net (note 6) of $29K in Q1 2026.
- How has Gyre Therapeutics, Inc.'s other income, net (note 6) changed year-over-year?
- Gyre Therapeutics, Inc.'s other income, net (note 6) decreased by 72.9% year-over-year, from $107K to $29K.
- What is the long-term trend for Gyre Therapeutics, Inc.'s other income, net (note 6)?
- Over 2 years (2023 to 2025), Gyre Therapeutics, Inc.'s other income, net (note 6) has grown at a -0.4% compound annual growth rate (CAGR), from -$1.52M to -$1.51M.
- What does other income, net (note 6) mean?
- This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.